Individuals infected with the human immunodeficiency virus (HIV), the etiologic agent of acquired immunodeficiency syndrome (AIDS), often show symptoms associated with reactivation of Epstein-Barr virus (EBV). In this study, we show that exposure of EBV-positive B lymphocytes to HIV-I in vitro induc
Differential induction of Epstein-barr virus-related antigens in human lymphoblastoid cells by virus-mediated cell-to-cell contact
✍ Scribed by T. Matsuo; K. Yamamoto; T. Osato
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- French
- Weight
- 533 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Differential induction of Epstein‐Barr virus (EBV)‐related antigens was observed after Sendai virusmediated fusion of producer and non‐producer cells with various human and mouse cells. The EBV‐determined early nuclear antigen (ENA), early antigen (EA) and viral capsid antigen (VCA) could be induced at a high rate in producer cells (P3HR‐1 and B95–8), normally expressing these antigens at very low frequency, as early as 12–24 h after fusion with each other or with human amnion FL cells. In contrast, only one antigen, ENA, was induced in producer cells following fusion with non‐producer cells. This limited induction occurred also in non‐producer cells fused with FL cells, but not after fusion with each other. EBV induction did not result from fusion of either producer or non‐producer cells with mouse cells (L‐M (TK^‐^) Cl1D and MCB‐6). The differential induction was not the result of heterokaryon formation as determined by autoradiography. The implications of these findings are discussed.
📜 SIMILAR VOLUMES
## Abstract Human lymphoblastoid lines of various origins which harbour Epstein‐Barr virus (EBV)‐specific nucleic acid were re‐exposed to EBV. Following infection, cells of the non‐virus‐producing lines, Raji and S 95, predominantly synthesized EBV‐specific early antigens (EA), whereas only a small
## Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells* Epstein-Barr virus-transformed human B cells (EBV-B cells), but not resting B cells or B cells activated by T cell-derived factors, have been shown to support the proliferation of tetanus
## Abstract The tumor promoter TPA (12‐0‐tetradecanoyl‐phorbol‐13‐acetate) efficiently induces the synthesis of Epstein‐Barr virus (EBV) antigens in EBV‐genome‐harboring human lymphoblastoid cells. We attempted to obtain information on the binding of TPA to cells and on the relationship between TPA
## Abstract Transformation of human leukocytes by the QIMR‐ WIL strain of EB virus in vitro involves co‐operation between adherent cells (probably macrophages) and non‐adherent cells (predominantly lymphocytes). It was shown that the proliferating cells were derived from the non‐adherent population
## Abstract Twenty‐nine lymphoblastoid lines and one IgE‐producing myeloma line of human origin were exposed to Epstein‐Barr virus (EBV) concentrates __in vitro__. The adsorption of the virus to the outer cell membrane was assessed by counting the number of direct membrane fluorescence‐positive cel